These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6438535)

  • 1. Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells.
    Mingari MC; Gerosa F; Carra G; Accolla RS; Moretta A; Zubler RH; Waldmann TA; Moretta L
    Nature; 1984 Dec 13-19; 312(5995):641-3. PubMed ID: 6438535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac.
    Rubin LA; Kurman CC; Biddison WE; Goldman ND; Nelson DL
    Hybridoma; 1985; 4(2):91-102. PubMed ID: 2408992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity.
    Chatenoud L; Dugas B; Beaurain G; Touam M; Drueke T; Vasquez A; Galanaud P; Bach JF; Delfraissy JF
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7457-61. PubMed ID: 3094009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration that human B cells respond differently to interleukin 2 and B cell differentiation factor based on their stages of maturation.
    Nakagawa T; Nakagawa N; Goldstein H; Volkman DJ; Fauci AS
    J Immunol; 1986 Nov; 137(10):3175-82. PubMed ID: 2945860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of interleukin 2-dependent and -independent B cell proliferation with monoclonal anti-interleukin 2 receptor antibody.
    Hashimoto N; Nabholz M; MacDonald HR; Zubler RH
    Eur J Immunol; 1986 Mar; 16(3):317-20. PubMed ID: 3082653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.
    Zubler RH; Lowenthal JW; Erard F; Hashimoto N; Devos R; MacDonald HR
    J Exp Med; 1984 Oct; 160(4):1170-83. PubMed ID: 6434689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function.
    Muraguchi A; Kehrl JH; Longo DL; Volkman DJ; Smith KA; Fauci AS
    J Exp Med; 1985 Jan; 161(1):181-97. PubMed ID: 2981952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation.
    Depper JM; Leonard WJ; Robb RJ; Waldmann TA; Greene WC
    J Immunol; 1983 Aug; 131(2):690-6. PubMed ID: 6408186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional significance of Tac antigen expressed on activated human T lymphocytes: Tac antigen interacts with T cell growth factor in cellular proliferation.
    Miyawaki T; Yachie A; Uwadana N; Ohzeki S; Nagaoki T; Taniguchi N
    J Immunol; 1982 Dec; 129(6):2474-8. PubMed ID: 6982926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human interleukin 2 acts as a B cell growth and differentiation promoting factor.
    Emmrich F; Moll H; Simon MM
    Immunobiology; 1985 Feb; 169(1):97-102. PubMed ID: 3921456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 effects on human B cells activated in vivo.
    Miyawaki T; Suzuki T; Butler JL; Cooper MD
    J Clin Immunol; 1987 Jul; 7(4):277-87. PubMed ID: 3038945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interleukin-2 receptor on normal and malignant lymphocytes.
    Waldmann TA
    Adv Exp Med Biol; 1987; 213():129-37. PubMed ID: 2888269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of interleukin 2 receptors on activated human B cells.
    Waldmann TA; Goldman CK; Robb RJ; Depper JM; Leonard WJ; Sharrow SO; Bongiovanni KF; Korsmeyer SJ; Greene WC
    J Exp Med; 1984 Nov; 160(5):1450-66. PubMed ID: 6092511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine lymphocytes exhibit heterogeneity in their proliferative responsiveness to calcium ionophore.
    Kakkanaiah VN; Nagarkatti PS; Nagarkatti M
    Cell Mol Biol (Noisy-le-grand); 1992; 38(5-6):533-43. PubMed ID: 1483106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperreactivity of activated B cells to B cell growth factor in patients with systemic lupus erythematosus.
    Ueda Y; Sakane T; Tsunematsu T
    J Immunol; 1989 Dec; 143(12):3988-93. PubMed ID: 2592765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
    Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
    J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cells as antigen-presenting cells: antigen-specific IL-2 production by cloned T cells without expression of IL-2 receptors.
    Kakiuchi T; Matsui M; Taira S; Nariuchi H; Osawa H; Diamantstein T
    Cell Immunol; 1987 Aug; 108(1):150-61. PubMed ID: 3111723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells.
    Ortega G; Robb RJ; Shevach EM; Malek TR
    J Immunol; 1984 Oct; 133(4):1970-5. PubMed ID: 6206144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of accessory cell requirement in inducing IL 2 responsiveness by human T4 lymphocytes that generate colonies under PHA stimulation.
    Oudrhiri N; Farcet JP; Gourdin MF; Divine M; Bouguet J; Fradelizi D; Reyes F
    J Immunol; 1985 Sep; 135(3):1813-8. PubMed ID: 3926884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.